Scientists at The Institute of Cancer Research, London, claim to have discovered what may cause some treatments to stop working in people living with bowel cancer.

Supernus Pharmaceuticals (Nasdaq: SUPN) is to buy Sage Therapeutics (Nasdaq: SAGE) for total consideration of around $795 million. Shares in Sage shot up by 35% amid the news by midday Monday, while ...

A second case of acute liver failure (ALF) resulting in the death has been reported in a young recipient of Elevidys ...

French drug developer Averoa today announced that the European Commission (EC) has granted marketing authorization for ...

Swiss pharma giant Roche announced today its decision to proceed with Phase III development of prasinezumab, an ...

TTAM Research Institute, a nonprofit public benefit corporation based in California and led by 23andMe co-founder and former ...

Boston, USA-based biotech Solu Therapeutics today announced the appointment of Enda Moran as chief operating officer (COO).

The US Food and Drug Administration (FDA) announced a forthcoming public advisory committee meeting (AdCom) of the Oncologic Drugs Advisory Committee to review GSK’s marketing application for Blenrep ...

China’s National Medical Products Administration (NMPA) held a meeting last week to conduct the 2024 annual review of the ...

French pharma major Sanofi and US partner Regeneron Pharmaceuticals yesterday presented positive results from the EVEREST ...

US healthcare giant Johnson & Johnson’s subsidiary Janssen-Cilag yesterday announced today new results from the Phase II RedirecTT-1 study evaluating the investigational combination of Talvey ...

Californian biotech Jasper Therapeutics presented data from the 180mg cohort of the company’s SPOTLIGHT Phase Ib/IIa study of ...